RAPT Nov 2024 2.500 call
| Previous close | 4.2000 |
| Open | N/A |
| Bid | 0.9000 |
| Ask | 1.8500 |
| Strike | 2.50 |
| Expiry date | 2024-11-15 |
| Day's range | 4.2000 - 4.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 50 |
Insider MonkeyShould You Sell Your Stake in RAPT Therapeutics (RAPT)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter the fund returned 5.77% (net), compared to a 7.58% return for the Russell 2000 Growth Index. Despite a decline in many equity markets in […]
ZacksDown -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround
Rapt Therapeutics (RAPT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ZacksRapt Therapeutics (RAPT) Loses -47.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Rapt Therapeutics (RAPT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
